Skip to content
Vivid Platform UK

Zimbabwe Rejects ‘Unbalanced’ US Healthcare Assistance Agreement Over Information Apprehensions

Health aid illustration
The proposed US financial assistance would have supported initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has turned down a substantial American health deal worth $367m (272 million pounds) over five years because of the United States' demand for sensitive biological samples.

This rejection became public after a internal memorandum from December was disclosed, which showed Head of State Emmerson Mnangagwa felt the deal was "unbalanced".

A government spokesman has since explained that the US was demanding access to biological samples for research and commercial gain but was not willing to guarantee the resulting advantages from any future treatments.

"We must now begin the difficult and regrettable task of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has urged more dialogue to secure a agreement suitable to both sides so the country's vital HIV programme can proceed.

Broader Background

This rejection comes after a similar case in Kenya, where a court halted a similar deal with the US after legal challenges were raised about the safety of citizens' medical information.

After returning to office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).

The agency had managed aid for the US government, but Trump stated its spending was "wasteful" and his government was pursuing government-to-government deals to boost transparency and accountability.

Based on reports, 16 nations in Africa have to date agreed to similar health pacts, constituting over $18.3bn of fresh investment.

Details of the Declined Deal

The funds for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this cooperation could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million currently on antiretroviral therapy via US-supported initiatives," Tremont added.

However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".

"Our nation was requested to surrender its genetic material and health information over an extended period, without any corresponding assurance of benefiting from any medical innovations – like new medicines or tests – that could be developed from that provided information," his statement read.

"Effectively, our nation would supply the raw materials for scientific discovery with no certainty that the resulting innovations would be available to our population should a future pandemic emerge."

National Interest and International Frameworks

Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were undermining frameworks previously set up through the global health agency.

The spokesperson cited its Pandemic Benefit-Sharing framework designed to manage future global health emergencies.

"This system is intended to guarantee that when a country provides its data, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to create them."

The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.

"We encourage ongoing discussions with our US partners on how subsequent collaboration might be designed in a way that respects the independence and interests of each country."

Health Experts Response

A leading public health body stated it understood the official position, but recommended that negotiations should continue given that much of the nation's Aids initiatives were funded by external financing.

"In cases where specific concerns arise, such as those relating to data governance or agreement terms, these can often be resolved through detailed discussion and negotiated safeguards," the group commented.

The situation emphasises the ongoing challenges between accepting vital international aid and protecting national sovereignty in an increasingly data-driven world.

EA
About the author

Eric Alexander

A tech strategist with over a decade of experience in digital transformation and innovation across European markets.

Vivid Platform UK

Type to search articles.